Christopher Peetz - 29 Sep 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
29 Sep 2021
Transactions value $
-$70,708
Form type
4
Filing time
01 Oct 2021, 20:00:58 UTC
Previous filing
27 Sep 2021
Next filing
29 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $0 +21,875 +7.75% $0 24,699 29 Sep 2021 Direct F1
transaction MIRM Common Stock Sale -$70,708 -3,672 -14.87% $19.26 21,027 01 Oct 2021 Direct F2
holding MIRM Common Stock 201,570 29 Sep 2021 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares became issuable upon the satisfaction of certain performance conditions that were established at the time of the Compensation Committee's approval of a performance-based restricted stock unit award on March 9, 2021. On September 29, 2021, the Compensation Committee certified the achievement of the performance criteria resulting in the vesting of 10,937 shares on September 29, 2021 and 10,938 shares on June 30, 2023.
F2 Shares sold to cover tax withholding obligations associated with the vesting of the performance-based restricted stock unit award granted to the Reporting Person on March 9, 2021.